Patient portals and other virtual health care options are expanding, with notable growth in patient portal messaging between 2020 and 2025.

Long-term eptinezumab treatment provides sustained reductions in headache burden for patients with highly refractory chronic migraine.

There is a negative correlation between self-management behavior and illness perception among people with inflammatory bowel disease.

Viloxazine extended-release shows promise for treating adults with ADHD who also experience symptoms of depression and anxiety.

About a fourth of teens and adults with Tourette syndrome or another tic disorder have attempted suicide at some point in their lives.

Nonmedical use of ADHD stimulants by adults is frequently motivated by a desire to improve concentration or stay alert and is often associated with other substance use disorders.

Self-reported interpersonal trauma correlates with increased cognitive disengagement syndrome symptoms in young adolescents.

Childhood inattentive ADHD symptoms are associated with adverse occupational outcomes and higher stress levels in adulthood.

Maternal vitamin D concentrations during pregnancy could influence the risk for ASD and ADHD symptoms in childhood and adolescence.

GLP-1 receptor agonists may lower the likelihood of psychiatric treatment intensification in patients with type 2 diabetes and depression.

Exposure to environmental chemicals during pregnancy is widespread, and some chemicals are associated with gestational changes.

The FDA has approved Amphastar's Rextovy (4mg naloxone HCl) nasal spray for over-the-counter use to treat adult and pediatric opioid overdoses.